TLPH · Talphera Inc
United States · RS rating 42 · As of 2026-11-03
| Price | 1.04 USD |
|---|---|
| 1-day change | +3.0% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 34 / 28 / 35 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 21 / 42 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +45.5% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +29.2% |
| Market cap (USD) | $40.0M |